logo-loader

Put British American Tobacco on the backburner, says Credit Suisse

Last updated: 06:58 24 Mar 2014 EDT, First published: 07:58 24 Mar 2014 EDT

cigarette_350_53301e2c216e7

British American Tobacco (LON:BATS) suffered a downgrade to ‘neutral’ on Monday as Credit Suisse removed its ‘outperform’ rating on the tobacco giant.

The Swiss broker trims its estimates by 3-5% following the recent annual results, lowering his price target by 50p to £35.

The company’s track record may be among the most impressive it has seen in the consumer staples sector, but lower earnings growth puts a slight dampener on its view, as do challenges in emerging markets and adverse currency movements.

Imperial Tobacco (LON:IMT) though retained its ‘outperform’ recommendation, with a higher target price of £27 from £26 previously.

The broker says that with scope for consolidation in the industry, it is possible that the ‘big four’ becomes the ‘big three’.

“We doubt IMT stays independent for ever,” Credit Suisse remarked.

As for the tobacco market in general, the broker sees volumes continuing to fall, but at a slower pace.

“We believe the markets will return to their previous, rather more steady declines (rather than the steeper falls of late), although not for a year or so.”


BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

1 hour, 8 minutes ago